Introduction Welcome to the UCB Newsroom, your source for the latest updates, press releases, and stories that showcase our commitment to advancing science and improving patient lives.Stay informed about our recent breakthroughs, partnerships, and innovations through our features and news updates. Latest press releases The press releases are intended for media and financial analysts Press release 6 Nov 2025 UCB Announces Strategic Executive Leadership Rotation to Drive Future Growth and Innovation Read More Press release 3 Nov 2025 U.S. FDA approves KYGEVVI[®] (doxecitine and doxribtimine), the first and only treatment for adults... Read More Press release 31 Oct 2025 BIMZELX[®] (bimekizumab-bkzx) data in hidradenitis suppurativa showed improvements in pain and... Read More Interested in more? Access our media image selection or contact us for particular requests.The UCB media relations team responds to calls and emails from professional journalists only. View all downloadable resources Contact us
Press release 6 Nov 2025 UCB Announces Strategic Executive Leadership Rotation to Drive Future Growth and Innovation Read More
Press release 3 Nov 2025 U.S. FDA approves KYGEVVI[®] (doxecitine and doxribtimine), the first and only treatment for adults... Read More
Press release 31 Oct 2025 BIMZELX[®] (bimekizumab-bkzx) data in hidradenitis suppurativa showed improvements in pain and... Read More
